Cargando…

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Xu, Qianhui, Xu, Hao, Deng, Rongshan, Li, Nanjun, Mu, Ruiqi, Qi, Zhixuan, Shen, Yunuo, Wang, Zijie, Wen, Jingchao, Zhao, Jiaxin, Weng, Di, Huang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383396/ https://www.ncbi.nlm.nih.gov/pubmed/34429123 http://dx.doi.org/10.1186/s12935-021-02139-9

Ejemplares similares

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological significance of survival-related alternative splicing in uveal melanoma
por: Kong, Deqian, et al.
Publicado: (2022)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma
por: Hu, Guanghui, et al.
Publicado: (2020)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Significance of alternative splicing in cancer cells
por: Qi, Fei, et al.
Publicado: (2020)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

Alternative splicing signatures in preimplantation embryo development
por: Tian, Geng G., et al.
Publicado: (2020)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

An alternative splicing signature in human Crohn’s disease
por: Li, Daowei, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Epigenetic features are significantly associated with alternative splicing
por: Zhou, Yuanpeng, et al.
Publicado: (2012)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2022)

Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2023)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Prognostic significance of survival-associated alternative splicing events in gastric cancer
por: Zhang, Shichao, et al.
Publicado: (2020)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance
por: Liu, Chuan, et al.
Publicado: (2020)

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2016)

Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data
por: Xu, Ning, et al.
Publicado: (2020)

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
por: Mao, Xiaoyu, et al.
Publicado: (2023)

An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma
por: Xu, Rui-Yao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kdv0hocnv8kct1nqac05jm5q6d